Kanglaite enhances the efficacy of cisplatin in suppression of hepatocellular carcinoma via inhibiting CKLF1 mediated NF-κB pathway and regulating transporter mediated drug efflux
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference74 articles.
1. IMM-H004 protects against cerebral ischemia injury and cardiopulmonary complications via CKLF1 mediated inflammation pathway in adult and aged rats;Ai;Int. J. Mol. Sci.,2019
2. IMM-H004 therapy for permanent focal ischemic cerebral injury via CKLF1/CCR4-mediated NLRP3 inflammasome activation;Ai;Transl. Res.,2019
3. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries;Allemani;Lancet,2018
4. Tyrosine kinase inhibitors as reversal agents for ABC transporter mediated drug resistance;Anreddy;Molecules,2014
5. Cancer-related inflammation: common themes and therapeutic opportunities;Balkwill;Semin. Canc. Biol.,2012
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Research on Coix seed as a food and medicinal resource, it's chemical components and their pharmacological activities: A review;Journal of Ethnopharmacology;2024-01
2. Ginsenoside Rg1 treats ischemic stroke by regulating CKLF1/CCR5 axis-induced neuronal cell pyroptosis;Phytomedicine;2024-01
3. Exploring the potential mechanisms of Yi-Yi-Fu-Zi-Bai-Jiang-San therapy on the immune-inflamed phenotype of colorectal cancer via combined network pharmacology and bioinformatics analyses;Computers in Biology and Medicine;2023-11
4. Effect of adlay seed extract on inflammation and fibrogenesis in human corneal activated keratocytes at transcriptional level;Experimental Eye Research;2023-10
5. Current Opinions on the Relationship Between CMTM Family and Hepatocellular Carcinoma;Journal of Hepatocellular Carcinoma;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3